Latest stories on EWTX
Edgewise Therapeutics Shareholders Back Board and Governance
TipRanks50 · neutralgeneral
Edgewise Therapeutics, Inc. (EWTX) files 8-K
SEC 8-K50 · neutralgeneral
Edgewise: 'Buy' On Muscular Dystrophy Program Sale And EDG-7500 Advancement
Seeking Alpha68 · bullishanalyst
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules | EWTX Stock News
StockTitan50 · neutralgeneral
Edgewise Therapeutics Sells Sevasemten, Refocuses on Cardiology
TipRanks42 · neutralproduct/pr
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026
PR Newswire50 · neutralproduct/pr